Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15
The partners will host a joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from November 18–19, 2024
On July 3, SelectScience and ELRIG will be hosting an online event showcasing advances in cell-based screening in drug discovery to extend high-quality content to the global audience
Partnership endorses mission to facilitate career progression and support life science industry growth
Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal free drug discovery
Group aims to support start-up businesses while expanding the ELRIG community
ELRIG Drug Discovery 2023 at ACC Liverpool, UK (October 18–19) to focus on diverse thinking and new perspectives
ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community
ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community
This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus
Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community
Major learned societies initiate two-year strategic alliance
Find out why PROTACs hold such promise in cancer drug discovery
Organoid expert reveals recent developments, benefits, and challenges in organoid research
Determining connections between genetic traits and diseases using genome-wide studies could help improve efficacy and safety of new therapeutic drug
ELRIG organisers explain why they believe sharing and communicating the latest research and advances in technology is key to overcoming challenges in drug discovery
The ELRIG annual conference celebrates its 10 year anniversary
Telford International Centre, 2nd-3rd September 2015
